Bangavax gets approval for human trial

Local pharmaceutical company Globe Biotech Ltd has gotten the approval to conduct a clinical trial of its COVID-19 vaccine Bangavax on humans. 

Bangladesh Medical Research Council (BMRC) gave the approval, Globe Biotech Senior Manager (Quality and Regulation) Dr Mohammad told Jago News on Tuesday. 

Earlier on November 1, Globe Biotech submitted a report of its vaccine trial on money, which delivered good results, to BMRC, he said.

AAM/SU